Monophosphoryl Lipid A
Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity
... Immunization of mice with LVS-V also protects against i.n. challenge with F. tularensis LVS. In our previous studies, all F. tularensis LVS challenge infections were i.p. While immunization with LVS-V protected fully and ...
15
Migration Gene Expression of Human Umbilical Cord Mesenchymal Stem Cells: A Comparison between Monophosphoryl Lipid A and Supernatant of Lactobacillus acidophilus
... The capacity of human umbilical cord mesenchymal stem cells (hUMSCs) for migration and homing is very important in regenerative medicine. A detoxified derivative of lipopolysaccharides (LPS) that lacks many of the ...
8
Vaccination with poly(D,L-lactide-co-glycolide) nanoparticles loaded with soluble <em>Leishmania</em> antigens and modified with a TNFα-mimicking peptide or monophosphoryl lipid A confers protection against experimental visceral leishmaniasis
... Abstract: Visceral leishmaniasis (VL) persists as a major public health problem, and since the existing chemotherapy is far from satisfactory, development of an effective vaccine emerges as the most appropriate strategy ...
16
Comparative Analysis of Bacillus subtilis Spores and Monophosphoryl Lipid A as Adjuvants of Protein-Based Mycobacterium tuberculosis-Based Vaccines: Partial Requirement for Interleukin-17A for Induction of Protective Immunity
... studies, spores used as adjuvants were shown to increase antibody and T cell responses to a coadministered soluble antigen (Ag), including both antigen-specific CD4 ⫹ and CD8 ⫹ T cell responses, as well as complement- ...
8
Single and Combination Herpes Simplex Virus Type 2 Glycoprotein Vaccines Adjuvanted with CpG Oligodeoxynucleotides or Monophosphoryl Lipid A Exhibit Differential Immunity That Is Not Correlated to Protection in Animal Models
... with monophosphoryl lipid A (MPL) and alum developed by GlaxoSmithKline (GSK) dem- onstrated significant protection from the acquisition of disease in HSV-1-seronegative women in two phase 3 clinical trials ...
8
Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy
... Neuroinflammation occurs in parallel with the pro- gression of the disease in α -synucleinopathies [14]. Microglial activation may trigger the release of deleteri- ous cytokines and chemokines, but it may also clear ...
13
Vaccination with toxofilin DNA in combination with an alum monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii
... A good vaccine also depends on the choice of adjuvants which play a key factor in dictating the effect- iveness of the immune response [14, 15]. Aluminum salts (alum) are the most widely used of adjuvants in vaccine ...
11
Enhanced Immunogenicity and Protective Efficacy of a Campylobacter jejuni Conjugate Vaccine Coadministered with Liposomes Containing Monophosphoryl Lipid A and QS-21
... ABSTRACT Campylobacter jejuni is among the most common causes of diarrheal disease worldwide and efforts to develop protective measures against the pathogen are ongoing. One of the few defined virulence factors targeted ...
18
A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines
... As depicted in Figure 6A, MPLA-tDCs and mDCs displayed a higher CCR7 and CXCR4 surface expression, both chemokine receptors involved in migratory response towards secondary lymphoid orga[r] ...
15
Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis
... These findings are in accord with the results of previous studies showing that peritoneal cells from these patients do not function as well as those obtained from patients with a low inc[r] ...
6
The Protective Role of Toll-like Receptors Agonist Monophosphoryl Lipid A against Vaccinated Murine Schistosomiasis
... Table 4: - Hepatic granuloma diameter in infected untreated and treated mice. Therefore, the assessment of the effect of MPLA adjuvant with protective 194[r] ...
15
NANOSTRUCTURED LIPID CARRIER: THE ADVANCED LIPID CARRIERS
... physiological lipid materials suitable for topical, dermal and transdermal ...of lipid nanoparticles attracting major attention as novel colloidal drug carriers for topical ...generation lipid ...
14
Formulation and Evaluation of Ketoprofen Gel Containing Solid Lipid Nanoparticles for Topical Application and its Suitable Analytical Method Development and Validation
... 6. In-vitro drug release: In-vitro release studies were performed using modified Franz diffusion cell 12 . Dialysis membrane (Himedia laboratories Pvt Ltd) having pore size 2.4 nm, molecular weight cut off 12,000–14,000 ...
10
PubMedCentral-PMC5853323.pdf
... lipid A (MPL, GlaxoSmithKline) and aluminum hydroxide (Brenntag Biosector, Denmark) on day 0 (dose 1) and again on day 28 (dose 2). Ten subjects each received 15 µg of VLP (subgroup A2) and 50 µg of VLP (subgroup ...
8
NMR lipid profiling and lipid metabolism in platelets
... Since this experiment was not designed to study the arachidonic acid metabolic pathways, it was quite difficult to ascertain the levels of arachidonate metabolites that were derived from the utilized arachidonic acid ...
267
Potential effects of samsum ant, Brachyponera sennaarensis, venom on TNF-α/NF-κB mediated inflammation in CCL4-toxicity in vivo
... Lipid peroxidation in homogenates was estimated spec- trophotometrically following the method described by Okhawa et al. [13, 14]. An aliquot of 0.5 ml of the result- ing supernatant was shaken with 2.5 ml of 20% ...
11
Carbon nanotubes for stabilization of nanostructured lipid particles
... crystalline lipid phases interacting with carbon nanotubes could differ from lipid to lipid 21 as well as with physicochemical ...23 Lipid nanostructures are also used for many applications, ...
7
The role of species specific modifications in peptidoglycan biosynthesis
... UDP-MurNAc-pentapeptide can be made in one step by enzymes MurA-MurF and their substrates (Section 2.6.1 and 3.1.3). UDP-MurNAc-pentapeptide (Glu) was made according to a published method (Lloyd et al., 2008). Work by Dr ...
391
Novel formulation of a methotrexate derivative with a lipid nanoemulsion
... the lipid nano- emulsion (1 mL, 30 mg of total lipids) by solubilization of ddMTX in ethanol (10% v:v) and adding it into the emul- ...the lipid nanoemulsion was measured in 20 µ L of the previous solution ...
11
Antioxidant effect of ascorbic acid on the quality of Cobia (Rachycentron canadum) fillets during frozen storage
... The effect of aqueous solutions of ascorbic acid (AA) on the rancidity development in Cobia (Rachycentron canadum) fillets during frozen storage was studied. Cobia fillets were treated with ascorbic acid (AA 0.25% and AA ...
15